[1]
L. W. Vestermark, S. Larsen, B. Lindeløv, and L. Bastholt, “A phase II study of thalidomide in patients with brain metastases from malignant melanoma”, AO, vol. 47, no. 8, pp. 1526–1530, Jan. 2008.